Winsan (Shanghai) Medical Science and Technology Co., Ltd. provided earnings guidance for the year 2018. For the year, the company predicts a decrease of between RMB 18,422,200 and RMB 27,422,200 in its net profit owned by shareholders of the company in 2018 compared with the same period of the year before, with a year-on-year decrease of between 42.43% and 63.15% (based on the disclosed statistics according to relevant regulations). The net profit belonging to shareholders of the company after excluding extraordinary profit and loss will increase by between RMB 35,263,300 and RMB 42,763,300 compared with the same period of the year before (based on the disclosed statistics according to relevant regulations).